Claim: Did RFK Jr. accurately claim that 10 percent of women who take mifepristone end up in the emergency room?

First requested: May 23, 2026 at 7:37 PM
22%

IsItCap Score

Truth Potential Meter

Not Credible

AI consensusMedium

Grader consensus is moderate.
Range 18%–25% (spread Δ7).
The graders lean in the same direction but differ on strength. Skim the summary and sources.
Read analysis summary

OpenAI Grade

0%
20%
40%
60%
80%
25%

Perplexity Grade

0%
20%
40%
60%
80%
18%

Google Gemini Grade

0%
20%
40%
60%
80%
20%
Shareable summary
Verdict: Questionable
  • Experts say the 10% figure is not an ER-visit rate.
  • The referenced report is described as non-peer-reviewed and methodologically disputed.
/r/rfk-jr-mifepristone-er-visits

Analysis Summary

RFK Jr.'s claim that 10 percent of women who take mifepristone end up in the emergency room is mostly false. Experts and medical sources widely dispute this figure, citing that serious complications are typically much lower, often below 1%. The claim is based on a report that has been criticized for its methodology and definitions of adverse events. While some studies indicate increased ER visits after mifepristone use, they do not support the specific 10% figure RFK Jr. cited. Critics argue that the interpretation of the data is misleading and not representative of actual ER visit rates related to mifepristone use. The evidence indicates that the claim lacks support from credible medical research, with experts emphasizing that normal complications are often misclassified as serious adverse events. The consensus among health professionals is that the actual risk of ER visits is significantly lower than what RFK Jr. suggests. All three graders point in the same direction, with minor differences. OpenAI comes in highest (25%), while Perplexity is lowest (18%). While RFK Jr.'s claim is largely disputed, some sources suggest that there may be increased ER visits associated with mifepristone use. However, these sources do not substantiate the specific 10% figure. The evidence indicates that the EPPC report he referenced is not peer-reviewed and has methodological flaws. This uncertainty does not change the overall verdict, as the majority of credible sources indicate that the claim is exaggerated and misleading.

Source quality

Truth (from sources)2.00 / 10
Source reliability3.00 / 10
Source independence4.00 / 10

Claim checks

Fits established facts3.00 / 10
Logical consistency3.00 / 10
Expert consensus2.00 / 10

Source Analysis

Common arguments
Supporting the claim
  • A cited report in the coverage reports nearly 11% serious adverse events after mifepristone.
  • Emergency room visits can be included in broad adverse-event counting.
  • One cohort study found higher ER utilization after medication abortion than surgical abortion.
Against the claim
  • Experts say the 10% figure is not an ER-visit rate.
  • The referenced report is described as non-peer-reviewed and methodologically disputed.
  • Other studies cited in coverage put serious complication rates far below 1%.

Mainstream Sources

Publication

cbsnews.com

Title

Kennedy says FDA is reviewing safety of abortion pill mifepristone

Summary

CBS News reports on RFK Jr.'s comments and the EPPC claim of nearly 11% serious adverse events after mifepristone, while also quoting medical experts and advocacy groups disputing that interpretation.

Source details

Publication

motherjones.com

Title

RFK Jr. Is Coming for Abortion Pills

Summary

Mother Jones analyzes the EPPC report RFK Jr. referenced and explains why experts say its 10%-plus figure is misleading and not equivalent to a true ER or serious-complication rate.

Source details

Publication

endocrinologyadvisor.com

Title

RFK Jr Calls for a Review of Abortion Pill Mifepristone

Summary

This medical news source reports that the EPPC report RFK Jr. referenced is not peer-reviewed and that clinicians say its 1-in-10 claim is misleading and not the same as an ER-visit rate.

Source details

Alternative Sources

Publication

pmc.ncbi.nlm.nih.gov

Title

A Longitudinal Cohort Study of Emergency Room Utilization After Mifepristone and Surgical Abortion

Summary

This peer-reviewed cohort study found ER visit rates increased over time after both medication and surgical abortions, and medication abortion was associated with higher ER utilization than surgical abortion in the study period.

Source details

Analysis Breakdown

True/False Spectrum (2.0)Source Credibility (3.0)Bias Assessment (4.0)Contextual Integrity (3.0)Content Coherence (3.0)Expert Consensus (2.0)28%

How to read the breakdown

Weakest areas
Truth2.0/10Consensus2.0/10
  • Truth: how well sources support the core claim.
  • Source reliability: whether the sources have a strong track record.
  • Independence: whether coverage looks one-sided or recycled.
  • Context: missing details (timeframe, definitions, scope) that change meaning.
  • Tip: if graders disagree, rely more on the summary + sources than the single number.

Detailed AnalysisPremium Feature

Get an in-depth analysis of content accuracy, source credibility, potential biases, contextual factors, claim origins, and hidden perspectives.

Create a free account to unlock premium features.

Methodology